Kronos Bio, Inc. (KRON)
NASDAQ: KRON · IEX Real-Time Price · USD
1.040
-0.010 (-0.95%)
May 8, 2024, 1:17 PM EDT - Market open
Kronos Bio Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Kronos Bio stock have an average target of 4.13, with a low estimate of 2.25 and a high estimate of 6.00. The average target predicts an increase of 297.12% from the current stock price of 1.04.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Kronos Bio stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2.5 → $2.25 | Strong Buy | Maintains | $2.5 → $2.25 | +116.35% | May 3, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +476.92% | Dec 19, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $2.5 | Strong Buy | Maintains | $9 → $2.5 | +140.38% | Dec 19, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +765.38% | Nov 27, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $9 | Strong Buy | Maintains | $10 → $9 | +765.38% | Aug 21, 2023 |
Financial Forecast
Revenue This Year
6.09M
from 6.29M
Decreased by -3.21%
Revenue Next Year
3.34M
from 6.09M
Decreased by -45.19%
EPS This Year
-1.57
from -1.95
EPS Next Year
-1.76
from -1.57
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 9.5M | 5.3M | n/a | 84.0M | 278.3M |
Avg | 6.1M | 3.3M | n/a | 81.6M | 270.3M |
Low | n/a | n/a | n/a | 78.4M | 259.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 50.3% | -13.7% | - | - | 241.0% |
Avg | -3.2% | -45.2% | - | - | 231.3% |
Low | - | - | - | - | 218.3% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -1.08 | -1.14 | -1.07 |
Avg | -1.57 | -1.76 | -1.80 |
Low | -2.01 | -2.04 | -2.45 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.